Balancing Blood Sugar and Brain Power as An Anti-Diabetic Drugs Classification and Basal Ganglia Function Study ...

Serious side effects of metformin are rare. Less serious side effects, like digestive issues and headaches, are common, but these usually go away with time. You can reduce the chances of side ...

The initiation of SGLT2 inhibitors vs DPP-4 inhibitors was associated with a 41% lower risk for mortality (hazard ratio [HR], 0.59; 95% CI, 0.45-0.77); the effect was more pronounced among women ...

Turchin, A., et al. (2025). Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2025.23067.

Pooling of the five trials reporting admission for heart failure provided moderate quality evidence for an increased risk in patients treated with DPP-4 inhibitors versus control (622/18554 v ...